Tissue inhibitor of metalloproteinase (timp) as a marker and predictor of cardiovascular disease and both cardiac and non-cardiac mortality.

“The present invention is directed to a method for characterizing an individual's risk profile of developing vascular disease, for an adverse outcome in a patient, for mortality in an individual diagnosed with vascular disease by evaluating the level of tissue inhibitor of metalloproteinase-1 (TIMP-1) in a sample taken from the individual. The invention is also directed to a kit for characterizing the same.”

Submitted December 2, 2004 by The Research Foundation of the State University of New York (SUNY). For more information, visit www.RFSUNY.org.